Biotech stocks rallied on Friday, led by Akari Therapeutics after encouraging preclinical pancreatic cancer data for AKTX-101. MetaVia, GeoVax, Polyrizon, and Sol-Gel also attracted buying interest. The move appears driven by positive pipeline sentiment rather than broader sector fundamentals.
Biotech stocks rallied on Friday, led by Akari Therapeutics after encouraging preclinical pancreatic cancer data for AKTX-101. MetaVia, GeoVax, Polyrizon, and Sol-Gel also attracted buying interest. The move appears driven by positive pipeline sentiment rather than broader sector fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
